Fingerprint
Dive into the research topics of 'Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically